Alternative molecular formats and therapeutic applications for bispecific antibodies, Mol. Immunol, vol.67, pp.95-106, 2015. ,
The making of bispecific antibodies, MAbs, vol.9, pp.182-212, 2017. ,
Antibody Structure and Function: The Basis for Engineering Therapeutics, Antibodies, vol.8, p.55, 2019. ,
Engineered antibody fragments and the rise of single domains, Nat. Biotechnol, vol.23, pp.1126-1136, 2005. ,
Evaluation of antibody fragment properties for near-infrared fluorescence imaging of HER3-positive cancer xenografts, Theranostics, vol.8, pp.4856-4869, 2018. ,
Structure-based engineering of a monoclonal antibody for improved solubility, Protein Eng. Des. Sel, vol.23, pp.643-651, 2010. ,
Toward aggregation-resistant antibodies by design, Trends Biotechnol, vol.31, pp.612-620, 2013. ,
A method to confer Protein L binding ability to any antibody fragment, MAbs, vol.8, pp.379-388, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02297085
Quality and cost assessment of a recombinant antibody fragment produced from mammalian, yeast and prokaryotic host cells: A case study prior to pharmaceutical development, New Biotechnol, vol.44, pp.31-40, 2018. ,
Design and Production of Bispecific Antibodies, Antibodies, vol.8, p.43, 2019. ,
Humanization of an anti-p185HER2 antibody for human cancer therapy, Proc. Natl. Acad. Sci, vol.89, pp.4285-4289, 1992. ,
Molecular engineering of antibodies for therapeutic and diagnostic purposes, MAbs, vol.4, pp.445-457, 2012. ,
Antibody humanization by structure-based computational protein design, MAbs, vol.7, pp.1045-1057, 2015. ,
Virtual mutation and directional evolution of anti-amoxicillin ScFv antibody for immunoassay of penicillins in milk, Anal. Biochem, vol.523, pp.44-45, 2017. ,
Design, development and characterization of ACT017, a humanized Fab that blocks platelet's glycoprotein VI function without causing bleeding risks, MAbs, vol.9, pp.945-958, 2017. ,
Humanization of rabbit monoclonal antibodies via grafting combined Kabat/IMGT/Paratome complementarity-determining regions: Rationale and examples, vol.9, pp.419-429, 2017. ,
Thermodynamic analyses of amino acid residues at the interface of an antibody B2212A and its antigen roundabout homolog 1, J. Biochem, vol.162, pp.255-258, 2017. ,
Improvement in affinity and thermostability of a fully human antibody against interleukin-17A by yeast-display technology and CDR grafting, Acta Pharm. Sin. B, vol.9, pp.960-972, 2019. ,
A combination of structural and empirical analyses delineates the key contacts mediating stability and affinity increases in an optimized biotherapeutmrtic single-chain Fv (scFv), J. Biol. Chem, vol.291, pp.1267-1276, 2016. ,
Stability engineering of scFvs for the development of bispecific and multivalent antibodies, Protein Eng. Des. Sel, vol.23, pp.549-557, 2010. ,
Antibody Affinity and Stability Maturation by Error-Prone PCR, In Methods in Molecular Biology, vol.1701, pp.393-407, 2018. ,
Antibody variable domain interface and framework sequence requirements for stability and function by high-throughput experiments, Structure, vol.22, pp.22-34, 2014. ,
A single mutation in framework 2 of the heavy variable domain improves the properties of a diabody and a related single-chain antibody, J. Mol. Biol, vol.423, pp.337-350, 2012. ,
Evaluation of three different formats of a neutralizing single chain human antibody against toxin Cn2: Neutralization capacity versus thermodynamic stability, Immunol. Lett, vol.143, pp.152-160, 2012. ,
Antibody scFv fragments without disulfide bonds made by molecular evolution, J. Mol. Biol, vol.275, pp.245-253, 1998. ,
Towards the improvement in stability of an anti-A? single-chain variable fragment, scFv-h3D6, as a way to enhance its therapeutic potential, vol.24, pp.167-175, 2017. ,
Brief Communication Structure-Based Design of Supercharged, Highly Thermoresistant Antibodies, Chem. Biol, vol.19, pp.449-455, 2012. ,
Optimal charged mutations in the complementarity-determining regions that prevent domain antibody aggregation are dependent on the antibody scaffold, Protein Eng. Des. Sel, vol.27, pp.29-39, 2014. ,
The effect of charge mutations on the stability and aggregation of a human single chain Fv fragment, Eur. J. Pharm. Biopharm, vol.115, pp.18-30, 2017. ,
Improving the Developability of an Antigen Binding Fragment by Aspartate Substitutions, Biochemistry, vol.58, pp.2750-2759, 2019. ,
Boosting antibody developability through rational sequence optimization, MAbs, vol.7, pp.505-515, 2015. ,
Crystal Structure of the Complex between the Monomeric Form of Toxoplasma gondii Surface Antigen 1 (SAG1) and a Monoclonal Antibody that Mimics the Human Immune Response, J. Mol. Biol, vol.354, pp.447-458, 2005. ,
Enhancing the detection of Toxoplasma gondii via an anti-SAG1 scFv-alkaline phosphatase immunoconjugate, Biotechnol. Rep, vol.23, 2019. ,
IMGT/3dstructure-DB and IMGT/domaingapalign: A database and a tool for immunoglobulins or antibodies, T cell receptors, MHC, IgSF and MHcSF, Nucleic Acids Res, vol.38, pp.301-307, 2009. ,
Grafting of protein L-binding activity onto recombinant antibody fragments, Anal. Biochem, vol.388, pp.331-338, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-02664330
Design and reshaping of an scFv directed against human platelet glycoprotein VI with diagnostic potential, Anal. Biochem, vol.417, pp.274-282, 2011. ,
Diabody mixture providing full protection against experimental scorpion envenoming with crude Androctonus australis venom, J. Biol. Chem, vol.287, pp.14149-14156, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00701164
Antibody Fragments and Their Purification by Protein L Affinity Chromatography, Antibodies, vol.4, pp.259-277, 2015. ,
Human IgA Monoclonal Antibodies That Neutralize Poliovirus, Produced by Hybridomas and Recombinant Expression, Antibodies, vol.2020, issue.5 ,
IMGT standardized criteria for statistical analysis of immunoglobulin V-Region amino acid properties, J. Mol. Recognit, vol.17, pp.17-32, 2004. ,
The catalytic activity of a recombinant single chain variable fragment nucleic acid-hydrolysing antibody varies with fusion tag and expression host, Arch. Biochem. Biophys, vol.633, pp.110-117, 2017. ,
Comprehensive optimization of a single-chain variable domain antibody fragment as a targeting ligand for a cytotoxic nanoparticle, MAbs, vol.0862, pp.42-52, 2015. ,
Towards a universal disulphide stabilised single chain Fv format: Importance of interchain disulphide bond location and vLvH orientation, Protein Eng. Des. Sel, vol.25, pp.321-329, 2012. ,
Novel multispecific heterodimeric antibody format allowing modular assembly of variable domain fragments, MAbs, vol.9, pp.68-84, 2017. ,
Production, purification, and characterization of human scFv antibodies expressed in Saccharomyces cerevisiae, Pichia pastoris, and Escherichia coli, Protein Expr. Purif, vol.42, pp.255-267, 2005. ,
Design and evaluation of a diabody to improve protection against a potent scorpion neurotoxin, Cell. Mol. Life Sci, vol.60, pp.617-628, 2003. ,
URL : https://hal.archives-ouvertes.fr/hal-02671196